4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-25-015739
Options or other derivatives
- Chief Executive Officer acquired 8,572,080 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Rawcliffe Adrian Chief Executive Officer | 2025-02-20 | Grant or award · Option to purchase Ordinary Shares | +5,143,248 | 5,143,248 | D | ||
| Rawcliffe Adrian Chief Executive Officer | 2025-02-20 | Grant or award · Option to purchase Ordinary Shares | +3,428,832 | 3,428,832 | D | ||
Loading xslF345X05/tm257186-1_4seq1.xml…